{"id":"https://openalex.org/W4380264382","doi":"https://doi.org/10.3389/fmed.2023.1191315","title":"Chemo-radiotherapy with 177Lu-PLGA(RGF)-CXCR4L for the targeted treatment of colorectal cancer","display_name":"Chemo-radiotherapy with 177Lu-PLGA(RGF)-CXCR4L for the targeted treatment of colorectal cancer","publication_year":2023,"publication_date":"2023-06-12","ids":{"openalex":"https://openalex.org/W4380264382","doi":"https://doi.org/10.3389/fmed.2023.1191315","pmid":"https://pubmed.ncbi.nlm.nih.gov/37378300","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10292846"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2023.1191315","doi":"https://doi.org/10.3389/fmed.2023.1191315","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2023.1191315","pdf_url":null,"source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fmed.2023.1191315","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003550597","display_name":"Pedro Cruz-Nova","orcid":"https://orcid.org/0000-0001-5719-7324","observed_orcids":["https://orcid.org/0000-0001-5719-7324"]},"institutions":[{"id":"https://openalex.org/I4210093685","display_name":"Instituto Nacional de Investigaciones Nucleares","ror":"https://ror.org/00k7h5c65","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210093685"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Pedro Cruz-Nova","raw_affiliation_strings":["Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico","institution_ids":["https://openalex.org/I4210093685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001139065","display_name":"Brenda Gibbens-Bandala","orcid":"https://orcid.org/0000-0003-2419-0307","observed_orcids":["https://orcid.org/0000-0003-2419-0307"]},"institutions":[{"id":"https://openalex.org/I4210093685","display_name":"Instituto Nacional de Investigaciones Nucleares","ror":"https://ror.org/00k7h5c65","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210093685"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Brenda Gibbens-Bandala","raw_affiliation_strings":["Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico","institution_ids":["https://openalex.org/I4210093685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045790780","display_name":"Alejandra Ancira-Cortez","orcid":"https://orcid.org/0000-0001-8772-1078","observed_orcids":["https://orcid.org/0000-0001-8772-1078"]},"institutions":[{"id":"https://openalex.org/I4210093685","display_name":"Instituto Nacional de Investigaciones Nucleares","ror":"https://ror.org/00k7h5c65","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210093685"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Alejandra Ancira-Cortez","raw_affiliation_strings":["Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico","institution_ids":["https://openalex.org/I4210093685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062031676","display_name":"Gerardo Ram\u00edrez-Nava","orcid":"https://orcid.org/0000-0002-3128-1744","observed_orcids":["https://orcid.org/0000-0002-3128-1744"]},"institutions":[{"id":"https://openalex.org/I98461037","display_name":"Tecnol\u00f3gico de Monterrey","ror":"https://ror.org/03ayjn504","country_code":"MX","type":"education","lineage":["https://openalex.org/I98461037"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Gerardo Ram\u00edrez-Nava","raw_affiliation_strings":["Institute of Advanced Materials for Sustainable Manufacturing, Tecnol\u00f3gico de Monterrey, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Advanced Materials for Sustainable Manufacturing, Tecnol\u00f3gico de Monterrey, Mexico City, Mexico","institution_ids":["https://openalex.org/I98461037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037738920","display_name":"Clara Santos\u2010Cuevas","orcid":"https://orcid.org/0000-0001-5903-1598","observed_orcids":["https://orcid.org/0000-0001-5903-1598"]},"institutions":[{"id":"https://openalex.org/I4210093685","display_name":"Instituto Nacional de Investigaciones Nucleares","ror":"https://ror.org/00k7h5c65","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210093685"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Clara Santos-Cuevas","raw_affiliation_strings":["Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico","institution_ids":["https://openalex.org/I4210093685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023762195","display_name":"Myrna Luna\u2010Guti\u00e9rrez","orcid":"https://orcid.org/0000-0002-4082-3816","observed_orcids":["https://orcid.org/0000-0002-4082-3816"]},"institutions":[{"id":"https://openalex.org/I4210093685","display_name":"Instituto Nacional de Investigaciones Nucleares","ror":"https://ror.org/00k7h5c65","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210093685"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Myrna Luna-Guti\u00e9rrez","raw_affiliation_strings":["Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico","institution_ids":["https://openalex.org/I4210093685"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040251027","display_name":"Blanca Ocampo\u2010Garc\u00eda","orcid":"https://orcid.org/0000-0002-5831-8412","observed_orcids":["https://orcid.org/0000-0002-5831-8412"]},"institutions":[{"id":"https://openalex.org/I4210093685","display_name":"Instituto Nacional de Investigaciones Nucleares","ror":"https://ror.org/00k7h5c65","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210093685"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Blanca Ocampo-Garc\u00eda","raw_affiliation_strings":["Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, Estado de M\u00e9xico, Mexico","institution_ids":["https://openalex.org/I4210093685"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001139065","https://openalex.org/A5040251027"],"corresponding_institution_ids":["https://openalex.org/I4210093685"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":1.3481,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.76554359,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"1191315","last_page":"1191315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9032999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9032999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.08060000091791153,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/lutetium-177","display_name":"lutetium-177","score":0.8769999742507935},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.9010000228881836},{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.8930000066757202},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6949999928474426},{"id":"https://openalex.org/keywords/radiolabeled-nanoparticles","display_name":"radiolabeled nanoparticles","score":0.7049999833106995},{"id":"https://openalex.org/keywords/dota-chelator","display_name":"DOTA chelator","score":0.6470000147819519},{"id":"https://openalex.org/keywords/microfluidic-nanoparticle-synthesis","display_name":"microfluidic nanoparticle synthesis","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hct116-xenograft","display_name":"HCT116 xenograft","score":0.8330000042915344},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6470000147819519},{"id":"https://openalex.org/keywords/biokinetics","display_name":"biokinetics","score":0.5799999833106995},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6658687591552734},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6637468338012695},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5270690321922302},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.513067364692688},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.48297205567359924},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4432094991207123},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4132468104362488},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.41253039240837097},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3636855185031891},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3608591556549072},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25964850187301636},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.16400077939033508},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.152208149433136},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.11748915910720825},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.09354755282402039},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fmed.2023.1191315","doi":"https://doi.org/10.3389/fmed.2023.1191315","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2023.1191315","pdf_url":null,"source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10292846","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10292846","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10292846/pdf/fmed-10-1191315.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Med (Lausanne)","raw_type":"Text"},{"id":"pmid:37378300","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37378300","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:40823603a990461e9856085094bdbe1f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/40823603a990461e9856085094bdbe1f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Medicine, Vol 10 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmed.2023.1191315","doi":"https://doi.org/10.3389/fmed.2023.1191315","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2023.1191315","pdf_url":null,"source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2445379623","display_name":null,"funder_award_id":"A1-S-38087","funder_id":"https://openalex.org/F4320321739","funder_display_name":"Consejo Nacional de Ciencia y Tecnolog\u00eda"},{"id":"https://openalex.org/G6958583472","display_name":null,"funder_award_id":"A1-S-","funder_id":"https://openalex.org/F4320321739","funder_display_name":"Consejo Nacional de Ciencia y Tecnolog\u00eda"}],"funders":[{"id":"https://openalex.org/F4320321739","display_name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","ror":"https://ror.org/059ex5q34"},{"id":"https://openalex.org/F4320330892","display_name":"Consejo Mexiquense de Ciencia y Tecnolog\u00eda","ror":"https://ror.org/05k0wa595"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4380264382.pdf","grobid_xml":"https://content.openalex.org/works/W4380264382.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W124546504","https://openalex.org/W1511246213","https://openalex.org/W1604996052","https://openalex.org/W1928083400","https://openalex.org/W1969828087","https://openalex.org/W2013262011","https://openalex.org/W2020398834","https://openalex.org/W2029903184","https://openalex.org/W2037044297","https://openalex.org/W2077188806","https://openalex.org/W2079292309","https://openalex.org/W2087835012","https://openalex.org/W2154156196","https://openalex.org/W2233607184","https://openalex.org/W2519598273","https://openalex.org/W2586387449","https://openalex.org/W2596628993","https://openalex.org/W2782405156","https://openalex.org/W2790505196","https://openalex.org/W2791772888","https://openalex.org/W2796305651","https://openalex.org/W2898648097","https://openalex.org/W2898712541","https://openalex.org/W2913797367","https://openalex.org/W2935732657","https://openalex.org/W2946778965","https://openalex.org/W2951509935","https://openalex.org/W2965362447","https://openalex.org/W2965904563","https://openalex.org/W3005254147","https://openalex.org/W3006728494","https://openalex.org/W3027917879","https://openalex.org/W3040907792","https://openalex.org/W3042163371","https://openalex.org/W3044905603","https://openalex.org/W3084328567","https://openalex.org/W3087545431","https://openalex.org/W3099990658","https://openalex.org/W3127772819","https://openalex.org/W3135842759","https://openalex.org/W3152372660","https://openalex.org/W3159142721","https://openalex.org/W3172900253","https://openalex.org/W3179518911","https://openalex.org/W3180678232","https://openalex.org/W4213197580","https://openalex.org/W4220870211","https://openalex.org/W4233669846","https://openalex.org/W4310038928","https://openalex.org/W6794927564"],"related_works":["https://openalex.org/W7117991863","https://openalex.org/W7160125541","https://openalex.org/W4281249711","https://openalex.org/W4406780939","https://openalex.org/W6904047672","https://openalex.org/W3197767246","https://openalex.org/W7165692035","https://openalex.org/W4406687085","https://openalex.org/W4416324066","https://openalex.org/W4403193738"],"abstract_inverted_index":{"Introduction":[0],"More":[1],"than":[2,108],"1.9":[3],"million":[4],"new":[5],"cases":[6],"of":[7,35,41,71,182,189,228,264,271],"colorectal":[8,24,65,114,128,203,237,272],"cancer":[9,25,88,111,129,204,238],"and":[10,29,54,73,90,121,145,154,167,170,193,213,218,221,246,260],"935,000":[11],"deaths":[12],"were":[13,157,198],"estimated":[14],"to":[15,68,119],"have":[16,76],"occurred":[17],"worldwide":[18],"in":[19,32,79,106,134,194,225,234,252],"2020.":[20],"Therapies":[21],"for":[22,61,127],"metastatic":[23,64],"include":[26],"cytotoxic":[27],"chemotherapy":[28,72],"targeted":[30,125],"therapies":[31],"multiple":[33],"lines":[34,70],"treatment.":[36],"Nevertheless,":[37],"the":[38,101,160,165,201,261],"optimal":[39],"use":[40],"these":[42],"agents":[43],"has":[44],"not":[45],"yet":[46],"been":[47,77],"resolved.":[48],"Regorafenib":[49],"(RGF)":[50],"is":[51,100],"an":[52,235],"Food":[53],"Drug":[55],"Administration":[56],"(FDA)-authorized":[57],"multikinase":[58],"inhibitor":[59],"indicated":[60],"patients":[62],"with":[63,140,173,185],"cancer,":[66],"non-responding":[67],"priority":[69],"immunotherapy.":[74],"Nanoparticles":[75],"used":[78],"specific":[80],"applications,":[81],"such":[82],"as":[83,147,266],"site-specific":[84],"drug":[85],"delivery":[86],"systems,":[87],"therapy,":[89],"clinical":[91,262],"bioanalytical":[92],"diagnostics.":[93],"C-X-C":[94],"Chemokine":[95],"receptor":[96,105],"type":[97],"4":[98],"(CXCR4)":[99],"most":[102],"widely-expressed":[103],"chemokine":[104],"more":[107],"23":[109],"human":[110],"types,":[112],"including":[113],"cancer.":[115,273],"This":[116],"research":[117,254],"aimed":[118],"synthesize":[120],"preclinically":[122],"evaluate":[123],"a":[124,141,148,179,186,267],"nanosystem":[126,177],"chemo-radiotherapy":[130],"using":[131,159,200],"RGF":[132],"encapsulated":[133],"Poly(D,L-lactic-co-glycolic":[135],"acid)":[136],"(PLGA)":[137],"nanoparticles":[138,156,209],"coated":[139],"CXCR4":[142],"ligand":[143],"(CXCR4L)":[144],"177Lu":[146],"therapeutic":[149],"\u03b2-emitter.":[150],"Methods":[151],"Empty":[152],"PLGA":[153],"PLGA(RGF)":[155],"prepared":[158],"microfluidic":[161],"method,":[162],"followed":[163],"by":[164,215],"DOTA":[166],"CXCR4L":[168],"functionalization":[169],"nanoparticle":[171],"radiolabeling":[172],"177Lu.":[174],"The":[175,241],"final":[176],"gave":[178],"particle":[180],"size":[181],"280":[183],"nm":[184],"polydispersity":[187],"index":[188],"0.347.":[190],"In":[191],"vitro":[192],"vivo":[195,226],"toxicity":[196],"effects":[197],"assessed":[199],"HCT116":[202,236],"cell":[205,211],"line.":[206],"Results":[207],"177Lu-PLGA(RGF)-CXCR4L":[208,229,265],"decreased":[210],"viability":[212],"proliferation":[214],"inhibiting":[216],"Erk":[217],"Akt":[219],"phosphorylation":[220],"promoting":[222],"apoptosis.":[223],"Moreover,":[224],"administration":[227],"significantly":[230],"reduced":[231],"tumor":[232],"growth":[233],"xenograft":[239],"model.":[240],"biokinetic":[242],"profile":[243],"showed":[244],"hepatic":[245],"renal":[247],"elimination.":[248],"Discussion":[249],"Data":[250],"obtained":[251],"this":[253],"justify":[255],"additional":[256],"preclinical":[257],"safety":[258],"trials":[259],"evaluation":[263],"potential":[268],"combined":[269],"treatment":[270]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-12T00:00:00"}